Zimmer Biomet Holdings, Inc. (ZBH) - NYSE
  • Tue, Jun. 14, 7:41 AM
    • Zimmer Biomet (ZBH -0.8%announces the pricing of the previously announced underwritten secondary offering of 11,116,533 shares of its common stock by certain of its stockholders, consisting of affiliates of KKR, Goldman Sachs and TPG. The shares are being sold at $115.85 per share. The selling stockholders will receive all of the proceeds of the offering.
    • Closing date is June 16.
    • Shares are down 3% premarket.
    | Tue, Jun. 14, 7:41 AM
  • Tue, Jun. 7, 7:30 AM
    • Zimmer Biomet Holdings (NYSE:ZBH) acquires French spine surgery device maker LDR Holding Corp. (NASDAQ:LDRH) for $37 per share in cash (~$1B), almost a 64% premium to yesterday's close of $22.58. The deal should close in Q3. The transaction is expected to be neutral to non-GAAP EPS in 2017 and accretive thereafter.
    • LDR, founded in 2000, designs devices that make spine surgeries easier to perform while improving clinical outcomes in the treatment of spine disorders.
    • Zimmer Biomet reiterates its previous 2016 guidance of revenue growth of 2 - 3% and non-GAAP EPS of $7.85 - 8.00.
    • Update: On July 13, Zimmer announced that it successfully completed the tender offer. The number of shares tendered was 24,278,729 (82.7% of LDR's outstanding shares). Notices of Guaranteed Delivery were received for an additional 1,826,189 shares (6.2% of the total outstanding).
    | Tue, Jun. 7, 7:30 AM | 1 Comment
  • Apr. 24, 2014, 12:46 PM
    | Apr. 24, 2014, 12:46 PM
  • Apr. 24, 2014, 9:28 AM
    | Apr. 24, 2014, 9:28 AM | 1 Comment
  • Apr. 24, 2014, 7:21 AM
    • Zimmer (ZMH) has agreed to Biomet for $13.35B in cash and stock, with the deal including debt.
    • Zimmer shares are +6.3%. (PR)
    | Apr. 24, 2014, 7:21 AM
  • Feb. 26, 2014, 9:43 AM
    • Anika Therapeutics (ANIK) surges 41% to $48.67 following the FDA's approval of the company's Monovisc single injection for pain caused by osteoarthritis of the knee.
    • The authorization must feel pretty sweet for Anika - it first applied for approval over four years ago.
    • Summer Street has hiked its price target to $60 a share from a prior PT of $47.
    • "We believe this product will be competitive in a market that is becoming more focused on single-shot injections," Summer Street says.
    • There are 27M people in the U.S. who suffer from osteoarthritis, which occurs when cartilage breaks down in joints, causing pain and stiffness as bones rub together.
    • Sanofi (SNY +0.1%) and Zimmer (ZMH +0.4%) sell rival products.
    | Feb. 26, 2014, 9:43 AM
  • Jul. 10, 2013, 2:19 PM

    Zimmer Holdings (ZMH +1%) gains today after saying that it's begun distributing its APEX Spine System, a set of implants and instruments designed to correct a broad range of spinal deformities as well as complex and degenerative spinal diseases. Under the terms of a long-term agreement with SpineCraft, Zimmer Spine will exclusively market the APEX Spine System to healthcare organizations across the U.S., Canada, Australia and New Zealand.

    | Jul. 10, 2013, 2:19 PM
  • Apr. 5, 2013, 4:00 PM
    Zimmer Holdings (ZMH -1.9%) slips today as Credit Suisse cuts their estimates on the company's Q1 and its reiterated Neutral on the shares. The firm says that it's at the high-end of guidance range, and U.S. knee/hip market growth needs to be more carefully watched. The company lowers its 2013/2014/2015 EPS estimates to $5.74/$6.24/$6.83, from $5.76/$6.30/$6.92 respectively.
    | Apr. 5, 2013, 4:00 PM
  • Jan. 30, 2013, 1:28 PM

    Zimmer Holdings (ZMH -1%) slips on a downgrade to Hold at Summer Street on valuation. The stock has been on a tear since the beginning of the year, rising nearly 17% on optimism over FDA clearance to market iASSIST Knee for knee replacement procedures.

    | Jan. 30, 2013, 1:28 PM
  • Apr. 26, 2012, 9:20 AM

    Premarket gainers: PATK +26%. HTWR +15%. REGN +14%. NUAN +14%. LOGI +14%. VHC +12%. CTXS +12%. NRGY +10%. EQIX +9%. CRUS +8%. SPPI +8%. INCY +7%. XLNX +7%. WPI +7%. AMRN +5%. EA +7%. MWW +5%. AH +6%. PHM +6%. AIS +5%. AIXG +5%. LSI +4%. TS +3%. UN +3%. ZNGA +3%. FRO +3%. RDS +3%.
    Losers: FURX -28%. PCS -15%. HRB -15%. TQNT -14%. ALU -13%. TSPT -12%. AET -9%. PTX -7%. AKAM -6%. AZN -6%. ZMH -5%. DB -5%. HERO -5%. STD -5%. DOW -4%. CELG -4%. CS -4%. CROX -4%. GG -3%. BWA -3%. UNH -3%. LVS -3%. VALE -3%. UPS -3%. POT -3%.

    | Apr. 26, 2012, 9:20 AM
  • Dec. 20, 2011, 9:05 AM

    Premarket gainers: CSIQ +27%. PGNX +26%. AIS +17%. SLXP +11%. S +7%. CLWR +7%. JEF +6%. ALU +6%. NOK +5%. DB +5%. RIO +5%. MT +4%. STD +4%. BBVA +4%. STM +4%. VHC +4%. GSS +4%. ANR +4%. MS +4%. ERIC +4%. BHP +3%. ZMH +3%. VALE +3%. ITUB +3%. SNE +3%. C +3%. VE +3%. X +3%. MU +3%. HAL +3%. SI +3%.
    Losers: TRGT -22%. RHT -8%. GFA -4%.

    | Dec. 20, 2011, 9:05 AM
Company Description
Zimmer Biomet Holdings, Inc. designs, develops, manufactures, and markets orthopedic reconstructive, spinal and trauma devices, biologics, dental implants and related surgical products. The company also provides other healthcare related services. The Orthopedic reconstructive devices restore... More
Sector: Healthcare
Industry: Medical Appliances & Equipment
Country: United States